Skip to main content

Pancreatic Cancer Clinical Trials

Review the pancreatic cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 226-250 of 284

Remote Exercise and Nutritional Program for Prehabilitation in Pancreatic Cancer Patients before Surgery
Status: Active
Location: Moffitt Cancer Center, Tampa, Florida
Continuous Monitoring of Vital Signs and Laboratory Values to Reduce Side Effects in Cancer Patients Receiving Chemotherapy with Moderate or High Risk of Febrile Neutropenia or Immunotherapy, PR-DOC Trial
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Improving Quality of Care, Inclusivity, and Clinical Trial Participation in Black Patients with Gastrointestinal Cancer
Status: Active
Location: Case Comprehensive Cancer Center, Cleveland, Ohio
Exercise and Nutrition Prehabilitation Program in Improving Outcomes for Patients with Resectable or Locally Advanced Pancreatic Cancer Undergoing Chemotherapy and Radiation before Surgery
Status: Temporarily Closed to Accrual
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts
The Vanguard Study: Testing a New Way to Screen for Cancer
Status: Active
Location: 37 locations
LCAM for Hereditary Cancer Screening in Patients with Cancer, IMAGINE Study
Status: Active
Location: 5 locations
The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer
Status: Active
Location: 2 locations
Mutant KRAS-Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Improving Care after Inherited Cancer Testing (IMPACT) Study
Status: Active
Location: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
Lanreotide versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Status: Temporarily Closed to Accrual
Location: 118 locations
Improving Screening for Patients at High Risk for Pancreas Cancer using Magnetic Resonance CholangioPancreatography and Endoscopic Ultrasound
Status: Active
Location: 7 locations
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Status: Active
Location: 7 locations
Computed Tomography in Diagnosing Patients with Pancreatic, Hepatobiliary, or Gynecological Cancer
Status: Active
Location: 3 locations
An Investigational Scan (68Ga-FAPI-46 PET/CT) for the Imaging of Cancer-Associated Fibroblasts in Patients with Localized Pancreatic Ductal Adenocarcinoma
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
Status: Active
Location: 2 locations
Biomarker Testing (ctDNA Assay) for Improving Care in Patients with Resectable Pancreatic Cancer Undergoing Treatment with Curative Intent
Status: Active
Location: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
[18F]FTT Positron Emission Tomography/Computed Tomography for the Imaging of Pancreatic Neuroendocrine Tumors
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
PYLARIFY PET-CT for Detection of Metastasis in Pancreatic, Liver, or Breast Cancer
Status: Active
Location: UT MD Anderson Cancer Center, Houston, Texas
An Investigational Scan (FAP-2286 PET) for the Imaging of Solid Tumors
Status: Active
Location: University of California San Francisco, San Francisco, California
New PET Scan (68Ga-FAPI-46) for People with Cancers
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Multiparametric Ultrasound for the Imaging of Cancerous and Non-cancerous Tissue in the Pancreas and Thyroid
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Diffusion Basis Spectrum Imaging for Assessing Microenvironment Tumor Effects in Patients with Cervical or Pancreatic Cancer Undergoing Radiation Therapy, METEOR-CRATR Trial
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Intravital Microscopy in Human Solid Tumors
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
Status: Active
Location: Massachusetts General Hospital Cancer Center, Boston, Massachusetts